Navigation Links
EUSA Pharma Submits ERWINASE(R) Biologics License Application (BLA) for Treatment of Acute Lymphoblastic Leukemia
Date:11/9/2010

antly, both in the U.S. and further afield. In the coming months, EUSA plans to achieve pan-European authorization for ERWINASE, and our partners are pursuing regulatory approval in Japan and elsewhere. As a result, ERWINASE has the opportunity to become EUSA's second global product, marking the company's rapid transformation into a leading player in the specialty oncology field."

About acute lymphoblastic leukemia

Acute lymphoblastic leukemia (ALL) is the most commonly diagnosed childhood cancer [1]. ALL predominantly affects children and adolescents, who account for over 60% of the more than 5,000 new cases diagnosed in the U.S. each year [2]. ALL treatment is complex, involving a number of stages and many drugs, and includes asparaginase as an essential component of current protocols. Pediatric treatment is often highly successful, with remission rates of over 95% and 75 - 85% of treated children surviving for at least five years without recurrence of leukemia [1].

About ERWINASE

ERWINASE is an asparaginase enzyme that depletes the level of the amino acid asparagine in the bloodstream. Asparagine is essential for cell growth, and its removal from the blood inhibits the growth of cells associated with acute lymphoblastic leukemia. Asparaginase products are derived from bacteria, and up to 60% of patients develop antibodies to those produced by Escherichia coli [3]. ERWINASE, which is produced by Erwinia chrysanthemi, is immunologically distinct from these therapies and is suitable for patients with hypersensitivity to E. coli-derived treatments*. The BLA submission for ERWINASE includes data from a recent study in children with hypersensitivity to pegylated E. coli asparaginase, which will be presented at the American Society of Hematology in December 2010.

About EUSA Pharma

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage onc
'/>"/>

SOURCE EUSA Pharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments
2. Anadys Pharmaceuticals Reports Third Quarter 2010 Financial Results and Highlights
3. How IT Helps Solve Pharmas R&D Problems: in silico Drug Discovery
4. UK Pharmaceutical Market Overview - Pricing and reimbursement challenges dampen future growth
5. Opportunities in Emerging Pharma Markets: Strategies for Optimizing Growth in Key Regions and Therapeutic Areas
6. Tianyin Pharmaceutical Co., Inc. to Host First Quarter of Fiscal Year 2011 Earnings Conference Call on Thursday, November 11, 2010 at 9:00 a.m. ET
7. ShangPharma Announces Appointment of Benson Tsang as a Member of the Board of Directors and Audit Committee
8. NovaSperse(SM) Nanoparticle Innovator, PharmaNova, Inc., Awarded Four Government Grants Toward Development of New Therapeutic Products Under Congressional Qualifying Therapeutic Discovery Project Initiative
9. WuXi PharmaTech Awarded GLP Certificate from SFDA for Suzhou Toxicology Facility
10. EnVivo Pharmaceuticals Research Shows EVP-6124 Acts as Acetylcholine Co-Agonist
11. Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014  Trovagene, Inc., (NASDAQ: ... today that Alberto Bardelli , Ph.D., has joined ... the first to identify mutations in the kinase genes ... Currently, he is at the Department of Oncology, Torino ... Italy . "Alberto,s work ...
(Date:9/17/2014)...  Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL ), ... received an unsolicited, non-binding proposal from Endo International plc ... the outstanding shares of Auxilium common stock at a ... stock, subject to due diligence, financing and other conditions. ... received from Endo on Friday evening is reproduced below. ...
(Date:9/17/2014)... , Sept. 17, 2014 Research ... "Global Breast Cancer Market 2014-2018" report to ... by the uncontrolled growth of cancerous cells in the ... however, male breast cancer is rare. Histologically, breast cancer ... cancer and other undifferentiated carcinoma. Ductal carcinoma is the ...
Breaking Medicine Technology:Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board 2Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board 3Auxilium Responds To Unsolicited Proposal From Endo International 2Auxilium Responds To Unsolicited Proposal From Endo International 3Auxilium Responds To Unsolicited Proposal From Endo International 4Auxilium Responds To Unsolicited Proposal From Endo International 5Auxilium Responds To Unsolicited Proposal From Endo International 6Auxilium Responds To Unsolicited Proposal From Endo International 7Global Breast Cancer Market 2014-2018: Key Vendors are Astrazeneca, Eli Lilly and Company and F. Hoffmann-La Roche, Novartis and Sanofi-Aventis 2Global Breast Cancer Market 2014-2018: Key Vendors are Astrazeneca, Eli Lilly and Company and F. Hoffmann-La Roche, Novartis and Sanofi-Aventis 3
... (OTC Bulletin Board: CGNH ) announced today that ... 2 Class B common stockholders a "Stockholder Questionnaire," which the ... count of the Company,s shares currently held in "street ... If you have not received the Stockholder Questionnaires via ...
... VILLAGE, Nev., March 8, 2011 PDL BioPharma, Inc. (PDL) (Nasdaq: ... rate for its 2.00% Convertible Senior Notes due February 15, 2012 ... 15, 2015 (the 2015 Notes) effective March 7, 2011, in connection ... to all stockholders who own shares of PDL on March 8, ...
Cached Medicine Technology:CardioGenics Requests Stockholders to Participate in Stockholder Questionnaires 2PDL BioPharma Announces Conversion Rate Adjustments for 2.00% Convertible Senior Notes Due February 15, 2012 and 2.875% Convertible Senior Notes Due February 15, 2015 2
(Date:9/17/2014)... (PRWEB) September 17, 2014 ... Access Management (IdM/IAM) solutions and Boston Software ... their business partner relationship. Under the ... technology to automate functionality within its identity ... Software Systems provides healthcare automation platforms that ...
(Date:9/17/2014)... UK, September 17, 2014 The International Journal of ... opened up its archive of previously published content: after 24 ... A key aim of the IJS is to ... that by making these articles available to all will improve ... of IJS said, "The journal has always been ...
(Date:9/17/2014)... A recent study of 54,000 surgical patients ... these patients developed surgical site infections (SSIs), with 0.8% labeled ... average difference for each patient with an SSI and those ... by Marin Schweizer, PhD, of the Iowa City VA Health ... costs for the hospitals were 1.25 times more for patients ...
(Date:9/17/2014)... 2014 The probability of prostate cancer ... screening and examination, a healthy diet could decrease the ... Epicure with the Chef MDs, renowned Chef Vikram ... to prepare a delicious Fish Moilee. , Dr. Rusilko ... influence risk of prostate cancer, uncommonly found in Asian ...
(Date:9/17/2014)... Acceleratio Ltd., an innovative software ... 6.0 of Server Monitoring Toolkit , a ... reporting. It brings real-time server monitoring via a ... and enhanced features that significantly improve troubleshooting and ... provides agentless data collection, a user-friendly interface, and ...
Breaking Medicine News(10 mins):Health News:Tools4ever Partners with Boston Software Systems to Automate Identity and Password Management 2Health News:Tools4ever Partners with Boston Software Systems to Automate Identity and Password Management 3Health News:Tools4ever Partners with Boston Software Systems to Automate Identity and Password Management 4Health News:Three Ways to Minimize Costs Associated with Surgical Site Infections 2Health News:Boost Prostate Health with Epicure with the Chef MDs 2Health News:New Server Monitoring Toolkit v6 Brings Real-Time Windows Server Monitoring and New Server Reports 2Health News:New Server Monitoring Toolkit v6 Brings Real-Time Windows Server Monitoring and New Server Reports 3
... BURLINGTON, N.J., Aug. 5 Most people over the age ... to focus on nearby objects. Although this age related phenomena is ... Kajita Clinic in Tokyo, Japan and published in March, 2009 has ... in older subjects (mean age of 53.9 +/- 5.1 years) with ...
... , , WASHINGTON, Aug. ... its latest report on effective emergency management for people with ... Association of Emergency Managers, 2009 National Conference on ... Corps at the Hyatt Regency Crystal City Hotel, 2799 ...
... , Goal to Distinguish Science Questions from Policy ... Advisory Committees Solely of Members with Relevant Scientific Expertise; Improve ... 5 A bipartisan panel of top scientific and regulatory ... federal agencies to make specific changes in the regulatory process ...
... , , CINCINNATI, Aug. 5 ... STRM ) today announced that, in an effort to further ... independent, non-management director as the Company,s Chairman of the Board. ... current independent member of the Company,s Board of Directors, as Chairman ...
... , , BOULDER, Colo., Aug. 5 ... Organic Center) strongly refute the claim made by Dr. Alan Dangour and ... important., Left unchallenged, the U.K. team,s study and Dr. Dangour,s remarks ... organic food. Among the multiple missteps in the FSA,s analysis are ...
... , , CARLSBAD, ... their DNA recovery product, GenSolve(TM), is enabling independent groups, from diverse ... for microarray based genomic analysis and Illumina iSelect based genotyping. , ... 2 :107 (16 June 2009) and BMC Genetics 2009, 10 ...
Cached Medicine News:Health News:The Reduction of Eye Fatigue Improves Vision in Older Subjects 2Health News:Bipartisan Panel of Industry, NGO and Academic Experts Proposes New Rules for Science in Federal Regulation 2Health News:Bipartisan Panel of Industry, NGO and Academic Experts Proposes New Rules for Science in Federal Regulation 3Health News:Bipartisan Panel of Industry, NGO and Academic Experts Proposes New Rules for Science in Federal Regulation 4Health News:Bipartisan Panel of Industry, NGO and Academic Experts Proposes New Rules for Science in Federal Regulation 5Health News:Bipartisan Panel of Industry, NGO and Academic Experts Proposes New Rules for Science in Federal Regulation 6Health News:Streamline Health Appoints Jon Phillips Chairman of the Board of Directors 2Health News:Streamline Health Appoints Jon Phillips Chairman of the Board of Directors 3Health News:Streamline Health Appoints Jon Phillips Chairman of the Board of Directors 4Health News:Streamline Health Appoints Jon Phillips Chairman of the Board of Directors 5Health News:The Organic Center Refutes Misleading Nutritional Claims Made by United Kingdom's Food Standards Agency (FSA) in Agency Report on Health Value of Organic Foods 2Health News:GenVault's GenSolve(TM) Reagents Enable State-of-the-Art Genomic Analysis of Dried Blood Spots 2Health News:GenVault's GenSolve(TM) Reagents Enable State-of-the-Art Genomic Analysis of Dried Blood Spots 3
... protection, our conventional aprons are ... sturdy 2 webbed straps that ... hook fasteners. The straps can ... the apron. Our conventional apron ...
Unshielded...
... Triage BNP Test is the first ... measuring B-type natriuretic peptide (BNP) ,Cardiac ... in response to ventricular volume expansion ... of ventricular systolic and diastolic dysfunction. ...
... MOST Options System is designed to ... of the knee or hip to ... provides the potential for restoration of ... the requirements of a rotating hinge ...
Medicine Products: